2022年6月29日に、QYResearchは「グローバルIVT（Intravitreal Injection）注射剤に関する調査レポート, 2017年-2028年の市場推移と予測、会社別、地域別、製品別、アプリケーション別の情報」の調査資料を発表しました。IVT（Intravitreal Injection）注射剤の市場生産能力 ...

前方循環脳主幹動脈閉塞の患者を対象に、静注血栓溶解療法（IVT）後に血栓除去術を実施する場合の便益が発症から治療実施までの時間によって変化するかどうかを、無作為化試験6件の個別患者データのメタ解析で検討。 2313例（IVT＋血栓除去術群1160例 ...

- Geographic atrophy (GA) program introduced with complement Factor I (CFI), a key component of the complement cascade, as a payload and utilizing two intravitreal (IVT) capsids, 7m8 and LSV1 - - IVT ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and improve vision outcomes for patients with wet AMD ARTEMIS ...

A panel of ophthalmologists defined points of consensus for suprachoroidal space injections based on current published evidence. IVT is the primary method of delivering therapeutics in the eye, ...

May 4 (Reuters) - Adverum Biotechnologies Inc: * ADVERUM BIOTECHNOLOGIES REPORTS POSITIVE INTERIM DATA FROM COHORTS 1-3 OF OPTIC PHASE 1 TRIAL OF ADVM-022 INTRAVITREAL GENE THERAPY FOR WET AMD 登録するここ.

EB-105 Targets VEGF-A, -B, PlGF, Ang-2, and IL-6R Improvements in Visual Acuity and Retinal Edema Observed at All Dose Levels No Safety Issues Observed Following a Single Intravitreal (IVT) Injection ...

Multiple subcutaneous doses safe and well-tolerated >69% reduction in anti-VEGF intravitreal (IVT) treatment burden in study eyes >67% reduction in anti-VEGF IVT treatment in fellow eyes of bilateral ...